https://www.selleckchem.com/products/pu-h71.html
Moreover, the encapsulated CPT-11 can be retained within GPDC-MSNs in the blood circulation but undergo intracellular burst release, which facilitates the apoptosis of tumor cells. GPDC-MSNs significantly increased HCC selectivity in vivo and exhibited up to 25 times higher accumulation in tumor tissue than in normal hepatic tissue, thus achieving superior antitumor efficacy and low systemic toxicity. Conclusion This stepwise-responsive nanoparticle should serve as a valuable platform and promising strategy for HCC treatment. © The autho
Like
Comment
Share
